16.04
price up icon6.32%   0.96
 
loading
前日終値:
$15.08
開ける:
$15.67
24時間の取引高:
45,779
Relative Volume:
0.19
時価総額:
$2.05B
収益:
$7.50M
当期純損益:
$-81.89M
株価収益率:
0.3025
EPS:
53.0176
ネットキャッシュフロー:
$-63.58M
1週間 パフォーマンス:
+41.26%
1か月 パフォーマンス:
+57.81%
6か月 パフォーマンス:
-11.02%
1年 パフォーマンス:
+93.87%
1日の値動き範囲:
Value
$15.60
$16.22
1週間の範囲:
Value
$11.87
$16.22
52週間の値動き範囲:
Value
$5.78
$22.00

Mesoblast Ltd Adr Stock (MESO) Company Profile

Name
名前
Mesoblast Ltd Adr
Name
セクター
Healthcare (1167)
Name
電話
-
Name
住所
-
Name
職員
73
Name
Twitter
@Mesoblast
Name
次回の収益日
2025-02-24
Name
最新のSEC提出書
Name
MESO's Discussions on Twitter

MESO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MESO
Mesoblast Ltd Adr
16.06 1.40B 7.50M -81.89M -63.58M 53.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.20 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
574.96 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.11 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
574.33 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.65 29.19B 3.81B -644.79M -669.77M -6.24

Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-18 ダウングレード Jefferies Buy → Hold
2024-12-23 ダウングレード Jefferies Buy → Hold
2024-09-24 アップグレード Maxim Group Hold → Buy
2024-08-29 アップグレード Jefferies Hold → Buy
2024-07-23 アップグレード Piper Sandler Neutral → Overweight
2023-08-31 アップグレード Jefferies Hold → Buy
2023-08-07 ダウングレード Maxim Group Buy → Hold
2023-08-04 ダウングレード Piper Sandler Overweight → Neutral
2023-08-04 ダウングレード William Blair Outperform → Mkt Perform
2023-03-09 開始されました William Blair Outperform
2022-12-06 ダウングレード Jefferies Buy → Hold
2022-09-06 開始されました Piper Sandler Overweight
2021-04-07 アップグレード Maxim Group Hold → Buy
2020-12-22 ダウングレード Maxim Group Buy → Hold
2020-12-04 ダウングレード Chardan Capital Markets Neutral → Sell
2020-10-22 開始されました RBC Capital Mkts Sector Perform
2020-08-14 繰り返されました Maxim Group Buy
2020-05-28 繰り返されました H.C. Wainwright Buy
2019-01-31 再開されました H.C. Wainwright Buy
2018-03-22 ダウングレード Credit Suisse Neutral → Underperform
2018-02-28 繰り返されました Cantor Fitzgerald Buy
2017-08-31 開始されました Oppenheimer Outperform
2017-06-08 開始されました Cantor Fitzgerald Buy
すべてを表示

Mesoblast Ltd Adr (MESO) 最新ニュース

pulisher
Jul 18, 2025

Company’s Banking Stock: Dissecting a -4.28% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Novagold Resources Inc (NG) Stock: A Year of Decreases and Increases - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

TV’s 2025 Market Dance: Down -20.11% – Time to Invest? - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Cango Inc ADR (CANG) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Mesoblast Ltd ADR Inc. (MESO) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Innodata Inc (INOD) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

BILL Holdings Inc Inc. (BILL) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Burford Capital Limited: Navigating Market Fluctuations with a 3.10B Market Cap - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Chagee Holdings Ltd. ADR (CHA) Stock: A Year of Highs and Lows - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Nano X Imaging Ltd (NNOX) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

LU’s Stock Dilemma: Lufax Holding Ltd ADR’s Market Performance and Outlook - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

ZTO’s Stock Market Adventure: -5.37% YTD Growth Amidst Volatility - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

MGRX’s Market Whiplash: -74.88% YTD Decline, -16.49% Plunge in 30 Days - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Mesoblast stock soars after reporting first Ryoncil sales - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Sonim Technologies Inc (SONM) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 18, 2025
pulisher
Jul 17, 2025

Successful Commercial Launch of Ryoncil® - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 14, 2025

An In-Depth Look at Trident Digital Tech Holdings Ltd. ADR Inc. (TDTH) Price Performance During Market Crashes - investchronicle.com

Jul 14, 2025
pulisher
Jul 14, 2025

BTCM: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com

Jul 14, 2025
pulisher
Jul 11, 2025

Perspective Therapeutics Inc (CATX Stock: A Sea of Opportunity - investchronicle.com

Jul 11, 2025
pulisher
Jul 10, 2025

DallasNews Corporation (DALN) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 10, 2025
pulisher
Jul 08, 2025

Company’s Banking Shares: Up -3.01% from 52-Week Low, But Can the Momentum Hold? - investchronicle.com

Jul 08, 2025
pulisher
Jul 07, 2025

TSM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 07, 2025
pulisher
Jul 01, 2025

GE Vernova Inc (GEV) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Jul 01, 2025
pulisher
Jun 20, 2025

Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Jun 20, 2025
pulisher
May 06, 2025

All Markets & Instruments Available to Trade - Capital.com

May 06, 2025
pulisher
Mar 30, 2025

Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil® - thecapitalclub.com.au

Mar 30, 2025
pulisher
Mar 20, 2025

UPDATED: Your guide to February Reporting Season 2020 - Morningstar.com.au

Mar 20, 2025
pulisher
Mar 03, 2025

21 Best-Performing Small-Cap Stocks for March 2025 - NerdWallet

Mar 03, 2025
pulisher
Feb 09, 2025

Why Mesoblast Ltd ADR (NASDAQ: MESO) Is Worth Including On Your Watchlist - Marketing Sentinel

Feb 09, 2025
pulisher
Feb 06, 2025

The 98.76% Simple Moving Average of Mesoblast Ltd ADR’s (MESO) Stock in the Past 200 Days - The News Heater

Feb 06, 2025
pulisher
Feb 01, 2025

Mesoblast Ltd ADR (NASDAQ:MESO) Shares Are Up 10.24 Percent In A Week – But Can The Gains Continue? - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 31, 2025

ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast - Stockhead

Jan 31, 2025
pulisher
Jan 10, 2025

Why are Mesoblast shares in a trading halt? - The Motley Fool Australia

Jan 10, 2025
pulisher
Jan 09, 2025

Mesoblast Limited Initiates Trading Halt Pending Financing Announcement - TipRanks

Jan 09, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Jan 02, 2025

Mesoblast (NASDAQ:MESO) Shares Gap UpWhat's Next? - MarketBeat

Jan 02, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 30, 2024

Mesoblast Stock Soars to 52-Week High, Hits $19.15 - Investing.com

Dec 30, 2024
pulisher
Dec 23, 2024

Mesoblast shares downgraded to hold by Jefferies By Investing.com - Investing.com South Africa

Dec 23, 2024
pulisher
Dec 20, 2024

Why the Mesoblast share price is diving 18% after an FDA win - The Motley Fool Australia

Dec 20, 2024
pulisher
Dec 19, 2024

Mesoblast share price rockets 30% on big US FDA news - The Motley Fool Australia

Dec 19, 2024
pulisher
Dec 16, 2024

Mesoblast stock soars to 52-week high, hits $12.21 - Investing.com

Dec 16, 2024
pulisher
Dec 03, 2024

Mesoblast Stock Soars to 52-Week High, Hits $12.19 - Investing.com

Dec 03, 2024
pulisher
Nov 13, 2024

Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com

Nov 13, 2024
pulisher
Oct 08, 2024

JPMorgan Takes Substantial Stake in Mesoblast Ltd - TipRanks

Oct 08, 2024
pulisher
Sep 30, 2024

Mesoblast to raise $50m from top shareholder for product launch - Capital Brief

Sep 30, 2024
pulisher
Jul 22, 2024

Mesoblast: Rolling The Dice On Cellular Medicines (NASDAQ:MESO) - Seeking Alpha

Jul 22, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Apr 10, 2024

Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha

Apr 10, 2024
pulisher
Mar 26, 2024

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - TradingView

Mar 26, 2024
pulisher
Mar 24, 2024

11 Best ASX Stocks To Buy Now - Yahoo Finance

Mar 24, 2024

Mesoblast Ltd Adr (MESO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$22.84
price up icon 4.79%
$36.02
price down icon 0.24%
$102.69
price down icon 0.29%
$27.91
price up icon 5.14%
$113.56
price up icon 1.86%
biotechnology ONC
$295.56
price down icon 0.03%
大文字化:     |  ボリューム (24 時間):